AAPL299.43+2.42 (+0.81%) ▲|ABBV234.34+4.33 (+1.88%) ▲|ABT90.27+2.44 (+2.77%) ▲|ACN126.48+1.65 (+1.32%) ▲|ADBE196.81+1.91 (+0.98%) ▲|AMAT582.66-57.52 (-8.99%) ▼|AMD521.69-29.94 (-5.43%) ▼|AMGN347.21+2.49 (+0.72%) ▲|AMT176.94+0.51 (+0.29%) ▲|AMZN234.09+1.30 (+0.56%) ▲|AVGO380.98-11.16 (-2.84%) ▼|AXP337.82-0.26 (-0.08%) ▼|BA218.75-2.08 (-0.94%) ▼|BAC57.84+0.47 (+0.82%) ▲|BKNG167.94+0.17 (+0.10%) ▲|BLK1,030.89-20.85 (-1.98%) ▼|BMY55.38+0.68 (+1.24%) ▲|BNY147.98+1.54 (+1.05%) ▲|BRK-B493.71+5.02 (+1.03%) ▲|C145.82+0.15 (+0.10%) ▲|CAT986.47-35.82 (-3.50%) ▼|CL90.92+2.25 (+2.54%) ▲|CMCSA22.78+0.46 (+2.04%) ▲|COF199.94-0.76 (-0.38%) ▼|COP110.10+0.40 (+0.36%) ▲|COST961.91+10.56 (+1.11%) ▲|CRM152.59+2.47 (+1.65%) ▲|CSCO119.59-1.94 (-1.60%) ▼|CVS101.82+0.52 (+0.51%) ▲|CVX175.65+0.59 (+0.34%) ▲|DE598.23-0.36 (-0.06%) ▼|DHR178.17-0.03 (-0.01%) ▼|DIS103.11+0.66 (+0.64%) ▲|DUK125.20+1.68 (+1.36%) ▲|EMR144.49-5.72 (-3.81%) ▼|FDX322.87-5.91 (-1.80%) ▼|GD348.01+4.65 (+1.35%) ▲|GE357.11+1.99 (+0.56%) ▲|GEV1,051.83-75.76 (-6.72%) ▼|GILD126.09+1.22 (+0.97%) ▲|GM79.48-0.96 (-1.19%) ▼|GOOG346.16-2.62 (-0.75%) ▼|GOOGL346.70-2.86 (-0.82%) ▼|GS1,099.85-6.52 (-0.59%) ▼|HD327.00+0.38 (+0.12%) ▲|HON224.81-3.31 (-1.45%) ▼|IBM265.24+13.02 (+5.16%) ▲|INTC135.87-5.07 (-3.60%) ▼|INTU260.03+2.26 (+0.87%) ▲|ISRG399.69-3.27 (-0.81%) ▼|JNJ235.47+4.18 (+1.81%) ▲|JPM334.79+3.31 (+1.00%) ▲|KO80.15+0.62 (+0.78%) ▲|LIN518.02+1.31 (+0.25%) ▲|LLY1,100.45-1.63 (-0.15%) ▼|LMT500.55+6.95 (+1.41%) ▲|LOW214.97+0.57 (+0.27%) ▲|LRCX368.16-41.39 (-10.11%) ▼|MA487.83+3.74 (+0.77%) ▲|MCD272.33+2.23 (+0.82%) ▲|MDLZ60.76+1.25 (+2.09%) ▲|MDT80.40+1.13 (+1.43%) ▲|META564.13+0.28 (+0.05%) ▲|MMM162.64-0.58 (-0.36%) ▼|MO71.09+1.58 (+2.27%) ▲|MRK118.26+2.78 (+2.41%) ▲|MS226.68-0.42 (-0.18%) ▼|MSFT374.62+7.28 (+1.98%) ▲|MU1,084.53-126.85 (-10.47%) ▼|NEE86.68+0.60 (+0.69%) ▲|NFLX72.69-0.19 (-0.26%) ▼|NKE42.42-0.77 (-1.78%) ▼|NOW96.71+3.70 (+3.98%) ▲|NVDA200.95-7.71 (-3.69%) ▼|ORCL170.02-5.06 (-2.89%) ▼|PEP141.65+0.94 (+0.67%) ▲|PFE24.87-0.21 (-0.84%) ▼|PG150.78+3.10 (+2.10%) ▲|PLTR118.58-0.92 (-0.77%) ▼|PM178.41+5.24 (+3.02%) ▲|QCOM199.77-22.13 (-9.97%) ▼|RTX183.96+2.13 (+1.17%) ▲|SBUX99.96-0.19 (-0.19%) ▼|SCHW92.83+0.80 (+0.87%) ▲|SO94.82+1.39 (+1.48%) ▲|SPG216.89+2.32 (+1.08%) ▲|T22.61+0.51 (+2.29%) ▲|TMO464.96+0.95 (+0.20%) ▲|TMUS182.64+2.58 (+1.43%) ▲|TSLA384.84-20.21 (-4.99%) ▼|TXN304.90-27.38 (-8.24%) ▼|UBER70.45-0.99 (-1.38%) ▼|UNH404.19-2.50 (-0.61%) ▼|UNP261.09+1.18 (+0.45%) ▲|UPS106.43-0.81 (-0.76%) ▼|USB59.60+0.92 (+1.57%) ▲|V330.90+4.30 (+1.32%) ▲|VZ46.09+0.73 (+1.60%) ▲|WFC84.02+0.18 (+0.21%) ▲|WMT119.63+2.45 (+2.09%) ▲|XOM139.47+1.00 (+0.72%) ▲|AAPL299.43+2.42 (+0.81%) ▲|ABBV234.34+4.33 (+1.88%) ▲|ABT90.27+2.44 (+2.77%) ▲|ACN126.48+1.65 (+1.32%) ▲|ADBE196.81+1.91 (+0.98%) ▲|AMAT582.66-57.52 (-8.99%) ▼|AMD521.69-29.94 (-5.43%) ▼|AMGN347.21+2.49 (+0.72%) ▲|AMT176.94+0.51 (+0.29%) ▲|AMZN234.09+1.30 (+0.56%) ▲|AVGO380.98-11.16 (-2.84%) ▼|AXP337.82-0.26 (-0.08%) ▼|BA218.75-2.08 (-0.94%) ▼|BAC57.84+0.47 (+0.82%) ▲|BKNG167.94+0.17 (+0.10%) ▲|BLK1,030.89-20.85 (-1.98%) ▼|BMY55.38+0.68 (+1.24%) ▲|BNY147.98+1.54 (+1.05%) ▲|BRK-B493.71+5.02 (+1.03%) ▲|C145.82+0.15 (+0.10%) ▲|CAT986.47-35.82 (-3.50%) ▼|CL90.92+2.25 (+2.54%) ▲|CMCSA22.78+0.46 (+2.04%) ▲|COF199.94-0.76 (-0.38%) ▼|COP110.10+0.40 (+0.36%) ▲|COST961.91+10.56 (+1.11%) ▲|CRM152.59+2.47 (+1.65%) ▲|CSCO119.59-1.94 (-1.60%) ▼|CVS101.82+0.52 (+0.51%) ▲|CVX175.65+0.59 (+0.34%) ▲|DE598.23-0.36 (-0.06%) ▼|DHR178.17-0.03 (-0.01%) ▼|DIS103.11+0.66 (+0.64%) ▲|DUK125.20+1.68 (+1.36%) ▲|EMR144.49-5.72 (-3.81%) ▼|FDX322.87-5.91 (-1.80%) ▼|GD348.01+4.65 (+1.35%) ▲|GE357.11+1.99 (+0.56%) ▲|GEV1,051.83-75.76 (-6.72%) ▼|GILD126.09+1.22 (+0.97%) ▲|GM79.48-0.96 (-1.19%) ▼|GOOG346.16-2.62 (-0.75%) ▼|GOOGL346.70-2.86 (-0.82%) ▼|GS1,099.85-6.52 (-0.59%) ▼|HD327.00+0.38 (+0.12%) ▲|HON224.81-3.31 (-1.45%) ▼|IBM265.24+13.02 (+5.16%) ▲|INTC135.87-5.07 (-3.60%) ▼|INTU260.03+2.26 (+0.87%) ▲|ISRG399.69-3.27 (-0.81%) ▼|JNJ235.47+4.18 (+1.81%) ▲|JPM334.79+3.31 (+1.00%) ▲|KO80.15+0.62 (+0.78%) ▲|LIN518.02+1.31 (+0.25%) ▲|LLY1,100.45-1.63 (-0.15%) ▼|LMT500.55+6.95 (+1.41%) ▲|LOW214.97+0.57 (+0.27%) ▲|LRCX368.16-41.39 (-10.11%) ▼|MA487.83+3.74 (+0.77%) ▲|MCD272.33+2.23 (+0.82%) ▲|MDLZ60.76+1.25 (+2.09%) ▲|MDT80.40+1.13 (+1.43%) ▲|META564.13+0.28 (+0.05%) ▲|MMM162.64-0.58 (-0.36%) ▼|MO71.09+1.58 (+2.27%) ▲|MRK118.26+2.78 (+2.41%) ▲|MS226.68-0.42 (-0.18%) ▼|MSFT374.62+7.28 (+1.98%) ▲|MU1,084.53-126.85 (-10.47%) ▼|NEE86.68+0.60 (+0.69%) ▲|NFLX72.69-0.19 (-0.26%) ▼|NKE42.42-0.77 (-1.78%) ▼|NOW96.71+3.70 (+3.98%) ▲|NVDA200.95-7.71 (-3.69%) ▼|ORCL170.02-5.06 (-2.89%) ▼|PEP141.65+0.94 (+0.67%) ▲|PFE24.87-0.21 (-0.84%) ▼|PG150.78+3.10 (+2.10%) ▲|PLTR118.58-0.92 (-0.77%) ▼|PM178.41+5.24 (+3.02%) ▲|QCOM199.77-22.13 (-9.97%) ▼|RTX183.96+2.13 (+1.17%) ▲|SBUX99.96-0.19 (-0.19%) ▼|SCHW92.83+0.80 (+0.87%) ▲|SO94.82+1.39 (+1.48%) ▲|SPG216.89+2.32 (+1.08%) ▲|T22.61+0.51 (+2.29%) ▲|TMO464.96+0.95 (+0.20%) ▲|TMUS182.64+2.58 (+1.43%) ▲|TSLA384.84-20.21 (-4.99%) ▼|TXN304.90-27.38 (-8.24%) ▼|UBER70.45-0.99 (-1.38%) ▼|UNH404.19-2.50 (-0.61%) ▼|UNP261.09+1.18 (+0.45%) ▲|UPS106.43-0.81 (-0.76%) ▼|USB59.60+0.92 (+1.57%) ▲|V330.90+4.30 (+1.32%) ▲|VZ46.09+0.73 (+1.60%) ▲|WFC84.02+0.18 (+0.21%) ▲|WMT119.63+2.45 (+2.09%) ▲|XOM139.47+1.00 (+0.72%) ▲|
20.6 C
New York
Tuesday, June 23, 2026

Tag: care

Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and...

ROCKVILLE, Md. and SUZHOU, China, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced that it has received clearance by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to conduct GLORA-4 study (NCT06641414), a global registrational Phase III study of lisaftoclax (APG-2575), a proprietary Bcl-2 inhibitor, in combination with azacitidine (AZA), for the treatment of patients with newly diagnosed higher-risk myelodysplastic syndrome (HR-MDS).

KLC INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against KinderCare Learning Companies, Inc. and Announces Opportunity for Investors with...

SAN DIEGO, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers of KinderCare Learning Companies, Inc. (NYSE: KLC) common stock in or traceable to KinderCare’s October 2024 initial public offering (“IPO”), have until October 13, 2025 to seek appointment as lead plaintiff of the KinderCare class action lawsuit. Captioned Gollapalli v. KinderCare Learning Companies, Inc., No. 25-cv-01424 (D. Or.), the KinderCare class action lawsuit charges KinderCare as well as certain of KinderCare’s top executives and directors, KinderCare’s controlling shareholder, and the underwriters of the IPO with violations of the Securities Act of 1933.

Sonicsmooth Pro+ Brings Professional-Style Dermaplaning and Exfoliation Home in 2025

At-home dermaplaning and exfoliation tool for smoother, brighter-looking skin
At-home dermaplaning and exfoliation tool for smoother, brighter-looking skin

Public health notice: Outbreak of Salmonella infections linked to various brands of pistachios and pistachio-containing products

August 15, 2025: Update OTTAWA, ON, Aug. 15, 2025 /CNW/ - This outbreak investigation is ongoing. The public health notice will be updated as the investigation...

PurelyWHITE Deluxe Teeth Whitening Powder 2025 Report: Whiten Your Smile Instantly With Zero Sensitivity

An In-Depth 2025 Analysis of PurelyWHITE Deluxe Teeth Whitening Powder and Consumer Trends in Sensitivity-Free Oral Care
An In-Depth 2025 Analysis of PurelyWHITE Deluxe Teeth Whitening Powder and Consumer Trends in Sensitivity-Free Oral Care

Galvanize Announces First Patient Enrolled in the PROPEL Registry Evaluating Aliya® Pulsed Electric Field Ablation for Soft Tissue Lesions

Multicenter Registry Launches to Assess Real-World Outcomes and Clinical Integration of Nonthermal Aliya PEF Ablation REDWOOD CITY, Calif., Aug. 15, 2025 /PRNewswire/ -- Galvanize Therapeutics...

Novo Nordisk A/S: Wegovy® approved in the US for the treatment of MASH

Bagsværd, Denmark, 15 August 2025 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved an additional indication for Wegovy® (semaglutide 2.4 mg) based on a supplemental New Drug Application (sNDA) for treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), in combination with a reduced calorie diet and increased physical activity.

KinderCare Learning (KLC) Faces IPO Investor Securities Class Action Amid Claims of Child Neglect – Hagens Berman

SAN FRANCISCO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit styled Gollapalli v. KinderCare Learning Companies, Inc., et al., No. 3:25-cv-01424 (D. Or.) has been filed and seeks to represent investors who purchased KinderCare (NYSE: KLC) common stock in or traceable to the company’s October 2024 IPO.

Nutex Health (NUTX) Delays Filing Quarterly Report, Shares Tank Again After Critical Blue Orca Report — Hagens Berman

SAN FRANCISCO, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Shares of Nutex Health Inc. (NASDAQ: NUTX) experienced a precipitous decline today, falling as much as 24% in intraday trading. The significant drop followed the company’s disclosure that it would not timely submit its financial results for the quarter ended June 30, 2025 - a development related to an ongoing investigation by law firm Hagens Berman into possible securities violations.

Jabez Biosciences, Inc. Opens Second Clinical Site in Phase 1 Oncology Clinical Study of JBZ-001

Jabez Biosciences Announces Opening of Second Clinical Site in Phase 1 study in Solid Tumors and NHL

InnovAge Florida PACE – Tampa and Tampa General Hospital Form Joint Venture to Elevate PACE Services in Tampa

InnovAge Florida PACE – Tampa and Tampa General Hospital Form Joint Venture to Elevate PACE Services in Tampa

MUCAR BT200 Max, Revolutionizing Car Maintenance with a Powerful New Diagnostic Solution

Ontario, California, Aug. 15, 2025 (GLOBE NEWSWIRE) --

MUCAR continues to push the boundaries of automotive technology. MUCAR, a pioneering name in automotive innovation, has unveiled its latest breakthrough: the MUCAR BT200 Max. 

The Right Fit: Footwear Brand FCTRY LAb Selects Barrett Distribution Centers for D2C Fulfillment

FRANKLIN, Mass., Aug. 15, 2025 /PRNewswire/ -- Barrett Distribution Centers is proud to announce a new partnership with FCTRY LAb, a trend-setting footwear company...

GoMo Health Launches the Women, Children and Families Engagement Hub to Improve Whole-Family Care and Health Outcomes In Every Life Stage

Holistic engagement programs offer healthcare organizations a scalable solution to support women and families in managing their physical, mental, and emotional health. ASBURY PARK, N.J.,...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCare